Procter & Gamble Co (PG)

PG (NYSE:Consumer Non-Durables) EQUITY
$91.09
pos +0.00
+0.00%
Today's Range: 90.45 - 91.36 | PG Avg Daily Volume: 9,298,800
Last Update: 02/17/17 - 4:00 PM EST
Volume: 0
YTD Performance: 8.34%
Open: $0.00
Previous Close: $90.79
52 Week Range: $79.10 - $91.36
Oustanding Shares: 2,556,477,220
Market Cap: 232,102,566,804
6-Month Chart
TheStreet Ratings Grade for PG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 9 9
Moderate Buy 2 2 2 1
Hold 7 7 4 5
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.25 2.25 1.88 1.94
Latest Dividend: 0.67
Latest Dividend Yield: 2.95%
Dividend Ex-Date: 01/18/17
Price Earnings Ratio: 26.32
Price Earnings Comparisons:
PG Sector Avg. S&P 500
26.32 28.50 30.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.65% 10.48% 14.72%
GROWTH 12 Mo 3 Yr CAGR
Revenue -8.20 -0.10 -0.03
Net Income -39.40 0.00 -0.01
EPS -40.10 -0.30 -0.13
Earnings for PG:
EBITDA 16.95B
Revenue 76.28B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (06/17) FY (06/18)
Average Estimate $0.93 $0.80 $3.86 $4.13
Number of Analysts 10 9 10 11
High Estimate $0.96 $0.83 $3.90 $4.20
Low Estimate $0.91 $0.77 $3.84 $4.07
Prior Year $0.86 $0.79 $3.67 $3.86
Growth Rate (Year over Year) 8.37% 1.55% 5.15% 7.02%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Doug Kass

 | Feb 15, 2017 | 3:49 PM EST
I started the day with a discussion of the new administration's policies and why I believe there are headwinds to their passage over the next few months or quarters. 
RMPIA
By

Jim Cramer

 | Feb 15, 2017 | 2:21 PM EST
Think of it as a consumer-products company, like Gillette.
By

Doug Kass

 | Feb 15, 2017 | 7:56 AM EST
I have covered my Procter & Gamble (PG) short rental from last night for a profit. …
RMPIA
By

Doug Kass

 | Feb 14, 2017 | 5:58 PM EST
Warren Buffett's Berkshire Hathaway (BRK.A) dramatically upped its Apple (AAPL) position (to 57 million shares), becoming a top 10 holder of the shares. SoftBank is close to acquiring Fortress Investment Group (FIG) for about $3 billion,
By

Bruce Kamich

 | Feb 10, 2017 | 9:24 AM EST
Stay long and look to add on strength.
By

Jim Cramer

 | Feb 8, 2017 | 5:52 AM EST
You want to sell Disney? Go ahead. I'll make money off you.
By

Doug Kass

 | Feb 2, 2017 | 11:36 AM EST
The continued U.S. dollar weakness is benefiting defensive consumer staples. Procter & Gamble  (PG) , Coca-Cola  (KO) …
By

Guy Ortmann

 | Jan 30, 2017 | 12:07 PM EST
The scale is weighted toward the bears and industrial names in particular.
RMPIA
By

Jim Cramer

 | Jan 30, 2017 | 7:12 AM EST
The stocks of companies that show good fundamentals are a buy, not a sell.
RMPIA
By

Doug Kass

 | Jan 26, 2017 | 4:08 PM EST
The U.S. Dollar strengthened. The price of crude oil rose by over one dollar to $53.78/barrel. Gold fell by -$8.60 to $1189. Ag commodities: wheat +2.50, corn -2.50, soybean -7 and oats -5.5. Lumber increased by $1.50. Bonds rallied in price after an early morning spill. Yields dropped by two basis points. The yield curve was flat. Municipal bonds were flat, as were closed end muni bond funds. Junk was unchanged, Blackstone/GSO Strategic Credit Fund (BGB)  down $0.03. Banks prospered, though Citigroup (C) was lower. Insurance was mixed after a Metlife (MET) downgrade. Brokerages solid, led by GS (short and on Best Ideas List). Big pharma continues out of favor after large downside at Bristol-Myers (BMY) . Johnson & Johnson (JNJ) continues weak, after M&A announcement. Retail continues to underperform and the possible 20% tariff from Mexico (that Sean Spicer just mentioned) won't help. Nor will the possibility of a Sears (SHLD) bankruptcy (plenty of discounted merchandise could cause some indigestion over the next few months. Old media was mixed, awaiting Microsoft (MSFT) EPS this afternoon. Biotech continued its fade led by Allergan (AGN) , Celgene (CELG) and Gilead Sciences (GILD) . Speculative biotech also got hit. Consumer staples faltered despite the currency weakness. Campbell Soup (CPB) and Procter &

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.